1Q27 Activity Report – Continued Operating Improvement 22 October 2026 Anagenics Limited (ASX:AN1, “Anagenics” or the “Company”) today provides an update on activities during the quarter ended 30 September 2026 (“1Q27”). During 1Q27 Operating Cash Outflows improved to $0.01m vs the...
AN1 - Appendix 4C & Activity Report for Q1 FY2027
Filed with ASX · · 6 pages · English
Summary by 6ix AI
Anagenics Limited has released its quarterly cash flow report and activity update for the first quarter of the fiscal year, highlighting continued operational improvements. The report indicates a significant reduction in operating cash outflows compared to the previous corresponding period, attributed to successful business restructuring. The company is now trading profitably and expects to generate positive operating cash flow moving forward. Additionally, royalty revenue from its product line has been reported, reflecting ongoing sales activity.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from Anagenics
- Notice of Annual General Meeting/Proxy Form
- AN1 FY26-Appendix-4E-
- AN1 - Appendix 4G JUN 2026
- AN1 2026 Annual Report
- Appendix 4C & Activity Report for Q4 FY2026
Later from Anagenics
- Pause in Trading
- Sale of Intellectual Property and Earn-Out Arrangement
- Anagenics to Acquire Bio-First Skincare Brand
- Proposed issue of securities - AN1
- Application for quotation of securities - AN1
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics